ES-Lomac L Capsule SR is a combination pharmaceutical formulation containing Levosulpiride 75 mg and Esomeprazole 40 mg, designed for the management of gastrointestinal disorders. Levosulpiride, a selective dopamine D2 receptor antagonist, exerts prokinetic and antiemetic effects by enhancing gastric motility and accelerating gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and dyspepsia. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, providing effective relief from acid-related disorders including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release formulation ensures a prolonged therapeutic effect, improving patient compliance and symptom control. ES-Lomac L Capsule SR is indicated for the treatment of functional dyspepsia, GERD, and other acid-peptic diseases where both acid suppression and improved gastric motility are desired. It should be used under medical supervision, considering contraindications such as hypersensitivity to either component and caution in patients with renal or hepatic impairment. Adverse effects may include headache, dizziness, and gastrointestinal disturbances. This combination therapy offers a synergistic approach for comprehensive management of upper gastrointestinal tract disorders.